ISRCTN ISRCTN43104115
DOI https://doi.org/10.1186/ISRCTN43104115
Secondary identifying numbers komc mirb 2010 - 01
Submission date
25/06/2010
Registration date
06/07/2010
Last edited
04/06/2015
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Nervous System Diseases
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English Summary

Not provided at time of registration

Contact information

Prof Jong-In Kim
Scientific

Dongdaemun-gu
Hoegi-dong #1
Kyung Hee Medical Center
Seoul
130-702
Korea, South

Email hann8400@hanmail.net

Study information

Study designRandomised assessor blind wait list controlled pilot trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Other
Study typeTreatment
Participant information sheet Not available in web format, please use contact details to request a patient information sheet
Scientific titleAcupuncture for Sequelae of Bell's Palsy: a randomised wait-list controlled pilot trial
Study hypothesisThe primary objective of the present protocol is to investigate the effectiveness of acupuncture in patients with sequelae of Bell's palsy, compared to a no-acupuncture waitlist status.
Ethics approval(s)Kyung-Hee University Medical Center Ethics Committee, 11/06/2010
ConditionSequelae of Bell's palsy
InterventionThe study includes the following periods in all groups: a treatment period of 8 weeks (3 sessions/week), and a follow-up period of 4 weeks.

Acupuncture group:
In the acupuncture treatment group, 18 acupuncture points (ipsilateral ST4, ST6 on the unaffected side, ipsilateral ST1, EX-HN4, TE23, LI20 on the affected side, and bilateral TE17, ST9, LI10, LI4, ST36, GB34) will be inserted with 0.20 mm in diameter x 30 mm in length disposal needles. The needle will be inserted to a depth of 5 - 10 mm, according to the points selected. The participating acupuncture doctors will manually manipulate the acupuncture needles with de-qi sensation and maintain the needles for 10 minutes.

Waitlist:
Participants who will be allocated to waitlist will receive no acupuncture treatment throughout the 8 weeks. After 8 weeks, if participants elect to try the acupuncture treatment it will be provided, acupuncture treatment period of 8 weeks (3 sessions/week).
Intervention typeOther
Primary outcome measureChanges in FDI (Facial Disability Index) after 24 sessions/8 weeks of acupuncture treatment.
Secondary outcome measuresChanges in the following, after 24 sessions/8 weeks of acupuncture treatment and one-month follow-up:
1. Sunnybrook Facial Grading System
2. H-B Scale
3. Lip-length and snout indices
4. Facial stiffness
Overall study start date01/08/2010
Overall study end date30/04/2011

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit18 Years
Upper age limit65 Years
SexBoth
Target number of participants20 participants in experiment group (acupuncture treatment), 10 participants in control group (wait list)
Participant inclusion criteria1. Aged between 18-65
2. Diagnosis of Bell's palsy (ICD-10 G51.0), at least 6 months prior to recruitment
3. FDI (Facial Disability Index) score of below 70 in Physical Function, and below 80 in Social/Well-being Function
4. Provided written informed consent
Participant exclusion criteria1. Secondary facial palsy resulting from specific disease such as infection, multiple neuritis, tumour invading the temporal region, cerebral contusion or stroke
2. Patient manifesting Ramsay-Hunt syndrome
3. Bilateral facial palsy
4. Recurred facial palsy
5. Received orally administered corticosteroids or anti-viral agent(aciclovir, valaciclovir, famciclovir, ganciclovir) within 1 month before enrolment
6. Received alternative and complementary modality, i.e. acupuncture, moxibustion, vesicant therapy or massage for treating Bell's palsy within 3 months
7. Received operation, i.e. facial nerve decompression, facial nerve and muscle reconstruction for treating Bell's palsy
8. Suffering serious medical condition such as uncontrolled hypertension, diabetes mellitus requiring insulin injection, past or current malignant tumour, severe dyslipidemia or liver and kidney dysfunction, anaemia, active pulmonary tuberculosis, other infectious disease or systemic diseases insufficient for acupuncture treatment
9. Other neurologic illness
10. Participating in another clinical trial
11. Suffering psychiatric illness insufficient for participation in clinical trial
12. Unable to obtain written consent
13. Pregnant or nursing status, or planning conception during treatment
14. Scar in administration area or systemic illness unsuitable for acupuncture treatment in the judgement of the investigator
Recruitment start date01/08/2010
Recruitment end date30/04/2011

Locations

Countries of recruitment

  • Korea, South

Study participating centre

Dongdaemun-gu
Seoul
130-702
Korea, South

Sponsor information

Kyung Hee University (South Korea)
University/education

Dongdaemun-gu
Hoegi-dong #1
Seoul
130-701
Korea, South

Email khsa0051@khu.ac.kr
ROR logo "ROR" https://ror.org/01zqcg218

Funders

Funder type

University/education

Kyung Hee University (South Korea) - Research Fund in 2010 (KHU-20100699)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Protocol article protocol 09/03/2011 Yes No
Results article results 03/06/2015 Yes No